A Manufacturing Solution
to Make Medicine Faster

Purchase clinical-grade AAV at a fraction of the time and cost

How can you know you’re putting your gene
therapy on the best path to patients?

Are you in a long waiting
list for AAV?
Are you nervous
about cost?
Do you need cGMP material?
Are you anxious about
study delays?
Request An Invitation

We're changing the way gene therapies are made

"AAV based gene therapy has proven itself as a way to treat previously untreatable diseases. Perception's technology dramatically reduces the time and cost of AAV production, which significantly increases the number of patients that could benefit."

Tim Day, PhDCo-founder and CSO, DNALite Therapeutics

"Existing technology that could be used to treat many genetic diseases is held back by slow infrastructure. We're building the tools to power the next thousand cures."

Omid Karkouti, MSFounder and CEO, Perception Biosystems
Request An Invitation

Our Investors